Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T18:07:49.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, with the 403 message shown near the top and site footer visible.
    Difference
    20%
    Check dated 2026-09-22T21:44:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    UI text for the contact information label is updated in capitalization, and a new Revision: v3.7.0 tag appears on the page.
    Difference
    0.1%
    Check dated 2026-09-15T21:55:53.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision stamp was updated to v3.6.6, replacing the previous v3.6.5. This signals a new build/update of the page without altering its visible content or functionality.
    Difference
    0.0%
    Check dated 2026-09-01T18:56:08.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 with dates 2026-08-04, 2026-08-03, 2026-08 and 2027-07 was added, and the previous revision block v3.6.4 was removed. This reflects metadata or versioning updates rather than substantive changes to study information.
    Difference
    0.3%
    Check dated 2026-08-11T08:33:20.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4. This signals a new version of the page content and metadata.
    Difference
    0.0%
    Check dated 2026-07-28T05:33:56.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.